Egis Pharmaceuticals's net debt reached HUF -43,021 mil and accounted for -0.240 of equity at the end of 2012. The ratio is down 19.6% when compared to the previous year.
Historically, the firm’s net debt to equity reached an all time high of < -0.001 in 2003 and an all time low of -0.240 in 2012.
When compared to EBITDA, net debt amounted to -1.41x at the end of the year. The ratio reached an all time high of -0.001 in 2003 and an all time low of -1.41 in 2012.
As far as Egis Pharmaceuticals's peers are concerned, Gedeon Richter posted net debt to equity of -0.054x and -0.373x when compared to EBITDA at the end of 2012. Krka ended the year 2012 with a net debt at 0.003x of equity and 0.012x when compared to its EBITDA while Krka had net debt at 0.003x of equity and 0.012x to EBITDA at the end of the year.